Clinical Trial Update: Feasibility of the Latella Implant System for Medial Osteoarthritis (OA) [NA]

View source ↗

Summary

The feasibility study of the Latella Implant System for medial osteoarthritis has been terminated; sponsor is Cotera, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Latella Implant System

Snippet

Sponsor: Cotera, Inc. | Conditions: Osteoarthritis | NA | Status: TERMINATED